Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.
Expression of a protective gene-prolongs survival of T cells in human immunodeficiency virus-infected patients.
Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):2889-94. Unique Identifier : AIDSLINE MED/96181502 Woffendin C; Ranga U; Yang Z; Xu L; Nabel GJ; Howard Hughes Medical Institute, University of Michigan Medical; Center, Ann Arbor 48109-0650, USA.
Abstract:
The resistance of acquired immunodeficiency syndrome (AIDS) to traditional drug therapy has prompted a search for alternative treatments for this disease. One potential approach is to provide genetic resistance to viral replication to prolong latency. This strategy requires the definition of effective antiviral genes that extend the survival of T cells in human immunodeficiency virus (HIV)-infected individuals. We report the results of a human study designed to determine whether a genetic intervention can prolong the survival of T cells in HIV-infected individuals. Gene transfer was performed in enriched CD4+ cells with plasmid expression vectors encoding an inhibitory Rev protein, Rev M10, or a deletion mutant control, deltaRev M10, delivered by gold microparticles. Autologous cells separately transfected with each of the vectors were returned to each patient, and toxicity, gene expression, and survival of genetically modified cells were assessed. Cells that expressed Rev M10 were more resistant to HIV infection than those with deltaRev M10 in vitro. In HIV-infected subjects, Rev M10-transduced cells showed preferential survival compared to deltaRev M10 controls. Rev M10 can therefore act as a specific intracellular inhibitor that can prolong T-cell survival in HIV-1-infected individuals and potentially serve as a molecular genetic intervention which can contribute to the treatment of AIDS.
Keywords: Acquired Immunodeficiency Syndrome/IMMUNOLOGY/MORTALITY/THERAPY Base Sequence Cell Survival CD4 Lymphocyte Count CD4-Positive T-Lymphocytes/PATHOLOGY/*PHYSIOLOGY DNA Primers Gene Products, rev/*BIOSYNTHESIS/GENETICS *Gene Therapy Gene Transfer *Genes, rev Genetic Vectors Human HIV Infections/*IMMUNOLOGY/MORTALITY/*THERAPY HIV-1 Lymphocyte Transfusion Male Molecular Sequence Data Polymerase Chain Reaction Sequence Deletion Support, U.S. Gov't, P.H.S. Survival Rate T-Lymphocytes/PATHOLOGY/*PHYSIOLOGY JOURNAL ARTICLE 960830
M9681149
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.
